Experimental MedicineProgram, University of British Columbia, British Columbia, Canada.
Br J Sports Med. 2009 Apr;43(4):303-6. doi: 10.1136/bjsm.2008.050021. Epub 2008 Nov 19.
To report on the effectiveness of sonographically guided injections of hyperosmolar dextrose at reducing the pain associated with chronic plantar fasciitis.
Case series.
Ultrasound division of St Paul's Hospital.
20 referrals (3 men, 17 women; age 51 (SD 13) years) from local sports medicine primary care practitioners who had failed previous conservative treatments.
A 27-gauge needle administered a 25% dextrose/lidocaine solution under sonographic guidance at 6 week intervals returning for a median of three consultations.
Visual analogue scale (VAS) items for pain levels at rest (VAS1), activities of daily living (VAS2), and during or after physical activity (VAS3) were recorded at baseline and at the final treatment consultation (post-test). A telephone interview conducted an average of 11.8 months after the post-test consultation provided a measure of long-term follow-up.
16 patients reported a good to excellent outcome, while the symptoms in 4 patients were unchanged. There was a significant decrease (p<0.001) in all mean VAS items from pre-test to post-test: VAS1 (36.8 (SD 25.6) to 10.3 (10.9)), VAS2 (74.7 (20.8) to 25.0 (27.7)) and VAS3 (91.6 (9.2) to 38.7 (35.1)) and there were no apparent changes after the follow-up interview.
Sonographically guided dextrose injections showed a good clinical response in patients with chronic plantar fasciitis insofar as pain was reduced during rest and activity. Further studies including a control group are needed to validate these outcomes.
报告超声引导下注射高渗葡萄糖治疗慢性足底筋膜炎疼痛的疗效。
病例系列。
圣保罗医院超声科。
20 名转诊患者(3 名男性,17 名女性;年龄 51(SD 13)岁),均来自当地运动医学初级保健医生,他们此前的保守治疗均失败。
在超声引导下,使用 27 号针注射 25%葡萄糖/利多卡因溶液,每 6 周 1 次,中位数接受 3 次治疗。
在基线和最后一次治疗咨询时(后测),采用视觉模拟量表(VAS)记录休息时(VAS1)、日常活动时(VAS2)和运动时或运动后(VAS3)的疼痛程度。在后测咨询后平均 11.8 个月进行电话访谈,提供长期随访结果。
16 名患者报告治疗效果良好或极好,4 名患者症状无变化。所有 VAS 评分在前后测均有显著降低(p<0.001):VAS1(36.8(SD 25.6)至 10.3(10.9))、VAS2(74.7(20.8)至 25.0(27.7))和 VAS3(91.6(9.2)至 38.7(35.1)),随访后无明显变化。
超声引导下注射高渗葡萄糖治疗慢性足底筋膜炎疼痛的临床效果较好,可降低休息和活动时的疼痛。需要进一步开展包括对照组在内的研究,以验证这些结果。